Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229074086> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W4229074086 endingPage "3117" @default.
- W4229074086 startingPage "3104" @default.
- W4229074086 abstract "Immune checkpoint inhibitors (ICIs) affect immunologic homeostasis, leading to immune-related adverse events (irAEs). Early irAE detection and management can prevent significant morbidity and mortality. A retrospective chart review was performed to characterize irAEs associated with nivolumab, ipilimumab, and nivolumab plus ipilimumab in adult medical oncology patients in Nova Scotia Health-Central Zone from 2013-2020, and to describe adherence to toxicity management guidelines. Diarrhea/colitis, hepatitis, pneumonitis, nephrotoxicity, and cardiotoxicity were studied. Of 129 charts reviewed, 67 patients (51.9%) experienced at least one irAE for a total of 98 irAEs and a 1.5% fatality rate. Of these irAEs, 33.7% led to an emergency room visit. Patients were admitted to hospital and steroids were used in 24.5% and 35.7% of cases, respectively. In 17.3% of irAEs, ICIs were permanently discontinued. In 20.4% of irAEs, ICIs were held, and patients were monitored; while in 18.4%, ICIs were held until the irAE was Grade 0-1 (and until steroids were tapered). Almost 47% of irAEs were managed according to guidelines (14.3% were not), and 38.8% had no documented management. Patients receiving immunotherapy frequently experience irAEs with half of irAEs having documented management adhering to guidelines. As immunotherapy indications expand, it is important to ensure irAEs are documented and managed appropriately." @default.
- W4229074086 created "2022-05-08" @default.
- W4229074086 creator A5001603544 @default.
- W4229074086 creator A5020539167 @default.
- W4229074086 creator A5047664971 @default.
- W4229074086 creator A5050312345 @default.
- W4229074086 creator A5060318509 @default.
- W4229074086 date "2022-04-28" @default.
- W4229074086 modified "2023-10-14" @default.
- W4229074086 title "Real-World Adherence to Toxicity Management Guidelines for Immune-Related Adverse Events" @default.
- W4229074086 cites W2314922821 @default.
- W4229074086 cites W2594042408 @default.
- W4229074086 cites W2606085194 @default.
- W4229074086 cites W2736166064 @default.
- W4229074086 cites W2743419024 @default.
- W4229074086 cites W2783137027 @default.
- W4229074086 cites W2786816161 @default.
- W4229074086 cites W2793180707 @default.
- W4229074086 cites W2809211230 @default.
- W4229074086 cites W2877328171 @default.
- W4229074086 cites W2891486030 @default.
- W4229074086 cites W2900174742 @default.
- W4229074086 cites W2901191795 @default.
- W4229074086 cites W2924070172 @default.
- W4229074086 cites W2925933490 @default.
- W4229074086 cites W2948123668 @default.
- W4229074086 cites W2976006709 @default.
- W4229074086 cites W2997720498 @default.
- W4229074086 cites W3004293125 @default.
- W4229074086 cites W3006654174 @default.
- W4229074086 cites W3006664585 @default.
- W4229074086 cites W3011192052 @default.
- W4229074086 cites W3015154527 @default.
- W4229074086 cites W3018517995 @default.
- W4229074086 cites W3047452123 @default.
- W4229074086 cites W3092802874 @default.
- W4229074086 cites W3189379297 @default.
- W4229074086 doi "https://doi.org/10.3390/curroncol29050252" @default.
- W4229074086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35621642" @default.
- W4229074086 hasPublicationYear "2022" @default.
- W4229074086 type Work @default.
- W4229074086 citedByCount "4" @default.
- W4229074086 countsByYear W42290740862022 @default.
- W4229074086 countsByYear W42290740862023 @default.
- W4229074086 crossrefType "journal-article" @default.
- W4229074086 hasAuthorship W4229074086A5001603544 @default.
- W4229074086 hasAuthorship W4229074086A5020539167 @default.
- W4229074086 hasAuthorship W4229074086A5047664971 @default.
- W4229074086 hasAuthorship W4229074086A5050312345 @default.
- W4229074086 hasAuthorship W4229074086A5060318509 @default.
- W4229074086 hasBestOaLocation W42290740861 @default.
- W4229074086 hasConcept C118552586 @default.
- W4229074086 hasConcept C121608353 @default.
- W4229074086 hasConcept C126322002 @default.
- W4229074086 hasConcept C197934379 @default.
- W4229074086 hasConcept C2777701055 @default.
- W4229074086 hasConcept C2779802037 @default.
- W4229074086 hasConcept C2780030458 @default.
- W4229074086 hasConcept C2780724011 @default.
- W4229074086 hasConcept C2781433595 @default.
- W4229074086 hasConcept C71924100 @default.
- W4229074086 hasConceptScore W4229074086C118552586 @default.
- W4229074086 hasConceptScore W4229074086C121608353 @default.
- W4229074086 hasConceptScore W4229074086C126322002 @default.
- W4229074086 hasConceptScore W4229074086C197934379 @default.
- W4229074086 hasConceptScore W4229074086C2777701055 @default.
- W4229074086 hasConceptScore W4229074086C2779802037 @default.
- W4229074086 hasConceptScore W4229074086C2780030458 @default.
- W4229074086 hasConceptScore W4229074086C2780724011 @default.
- W4229074086 hasConceptScore W4229074086C2781433595 @default.
- W4229074086 hasConceptScore W4229074086C71924100 @default.
- W4229074086 hasIssue "5" @default.
- W4229074086 hasLocation W42290740861 @default.
- W4229074086 hasLocation W42290740862 @default.
- W4229074086 hasLocation W42290740863 @default.
- W4229074086 hasOpenAccess W4229074086 @default.
- W4229074086 hasPrimaryLocation W42290740861 @default.
- W4229074086 hasRelatedWork W2783842152 @default.
- W4229074086 hasRelatedWork W2899127460 @default.
- W4229074086 hasRelatedWork W2983304924 @default.
- W4229074086 hasRelatedWork W3005150264 @default.
- W4229074086 hasRelatedWork W3016822790 @default.
- W4229074086 hasRelatedWork W3174164643 @default.
- W4229074086 hasRelatedWork W3175085288 @default.
- W4229074086 hasRelatedWork W3213713949 @default.
- W4229074086 hasRelatedWork W4206770832 @default.
- W4229074086 hasRelatedWork W4383822414 @default.
- W4229074086 hasVolume "29" @default.
- W4229074086 isParatext "false" @default.
- W4229074086 isRetracted "false" @default.
- W4229074086 workType "article" @default.